Berge, E. M., Aisner, D., & Doebele, R. C. (2013). Erlotinib response in a NSCLC patient with a novel compound G719D+L861R mutation in EGFR.
Citação norma ChicagoBerge, Eamon M., Dara Aisner, and Robert C. Doebele. Erlotinib Response in a NSCLC Patient With a Novel Compound G719D+L861R Mutation in EGFR. 2013.
MLA citiranjeBerge, Eamon M., Dara Aisner, and Robert C. Doebele. Erlotinib Response in a NSCLC Patient With a Novel Compound G719D+L861R Mutation in EGFR. 2013.
Opozorilo: Ti citati niso vedno 100% točni.